isoproterenol has been researched along with imatinib mesylate in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, GX; Fan, T; Hou, J; Liang, MY; Wang, LX; Wu, ZK; Yang, X; Yue, Y | 1 |
| Arbel, E; Krishnan, R; Lim, JM; Nayak, AP; Nguyen, TL; Penn, RB; Schaible, N; Tang, DD; Villalba, DR; Wang, R | 1 |
3 other study(ies) available for isoproterenol and imatinib mesylate
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Imatinib attenuates cardiac fibrosis by inhibiting platelet-derived growth factor receptors activation in isoproterenol induced model.
Topics: Animals; Cell Survival; Cells, Cultured; Echocardiography; Fibrosis; Gene Expression; Heart Diseases; Imatinib Mesylate; Isoproterenol; Male; Mice; Mice, Inbred C57BL; Phosphorylation; Receptors, Platelet-Derived Growth Factor; Ventricular Remodeling | 2017 |
Cooperativity between β-agonists and c-Abl inhibitors in regulating airway smooth muscle relaxation.
Topics: Actin Cytoskeleton; Adrenergic beta-Agonists; Animals; Antineoplastic Agents; Benzamides; Drug Synergism; Humans; Imatinib Mesylate; Isoproterenol; Mice; Mice, Inbred C57BL; Muscle Contraction; Muscle Relaxation; Muscle, Smooth; Proto-Oncogene Proteins c-abl; Pyrimidines; Signal Transduction; Trachea | 2021 |